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Background: The cardio-metabolic and antioxidant health benefits of caffeinated green tea (GT) relate to its
catechin polyphenol content. Less is known about decaffeinated extracts, particularly in combination with exercise.
The aim of this study was therefore to determine whether a decaffeinated green tea extract (dGTE) positively
influenced fat oxidation, body composition and exercise performance in recreationally active participants.
Methods: Fourteen, recreationally active males participated in a double-blind, placebo-controlled, parallel design
intervention (mean ± SE; age = 21.4 ± 0.3 yrs; weight = 76.37 ± 1.73 kg; body fat = 16.84 ± 0.97%, peak oxygen
consumption [ _VO2peak] = 3.00 ± 0.10 L·min
−1). Participants were randomly assigned capsulated dGTE (571 mg·d−1;
n = 7) or placebo (PL; n = 7) for 4 weeks. Following body composition and resting cardiovascular measures, participants
cycled for 1 hour at 50% _VO2peak, followed by a 40 minute performance trial at week 0, 2 and 4. Fat and carbohydrate
oxidation was assessed via indirect calorimetry. Pre-post exercise blood samples were collected for determination of
total fatty acids (TFA). Distance covered (km) and average power output (W) were assessed as exercise performance
criteria.
Results: Total fat oxidation rates increased by 24.9% from 0.241 ± 0.025 to 0.301 ± 0.009 g·min−1 with dGTE (P = 0.05;
ηp2 = 0.45) by week 4, whereas substrate utilisation was unaltered with PL. Body fat significantly decreased with dGTE
by 1.63 ± 0.16% in contrast to PL over the intervention period (P < 0.001; ηp2 = 0.84). No significant changes for FFA or
blood pressure between groups were observed. dGTE resulted in a 10.9% improvement in performance distance
covered from 20.23 ± 0.54 km to 22.43 ± 0.40 km by week 4 (P < 0.001; ηp2 = 0.85).
Conclusions: A 4 week dGTE intervention favourably enhanced substrate utilisation and subsequent performance
indices, but did not alter TFA concentrations in comparison to PL. The results support the use of catechin polyphenols
from dGTE in combination with exercise training in recreationally active volunteers.
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The health benefits of polyphenols found in green tea
(GT), the unfermented leaves of the tea plant, Camellia
sinensis, have been extensively investigated in the last
fifteen years [1-7]. Studies have demonstrated antioxi-
dant [8,9] and chemoprotective properties [4], as well as
improvements in cardio-metabolic health from various* Correspondence: justin.roberts@anglia.ac.uk
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unless otherwise stated.GT strategies (including reduced circulating cholesterol
and triglyerides [10], increased thermogenesis and whole
body fat oxidation [1,3,11], reduced blood pressure
[7,12,13] and improved body mass index ratios [5,14-17]).
These health benefits, in part, relate to the bioactive cat-
echin polyphenol content of GT, of which (−)-epigallocat-
echin-3-gallate (EGCG) can account for between 50–80%
of the total catechin content [18].
GT catechins have been proposed to influence meta-
bolic and thermogenic activities in the short term, via
inhibition of catechol-o-methyl transferase (COMT) lead-
ing to enhanced catecholamine, cAMP and lipolytic activityl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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catechins, particularly EGCG, may also activate endo-
thelial nitric oxide synthase, leading to mild reductions
in blood pressure [13,21].
In the longer term, GT catechins may influence
specific signalling molecules, including PGC1α, lead-
ing to gene expression of fat metabolism enzymes
[20]. Whilst such mechanisms are currently under de-
bate, strategies to enhance fat oxidation, body com-
position and cardiovascular efficiency in conjunction
with physical activity are of pertinence to the general
population. Additionally the indirect sparing of glyco-
gen stores may support improved exercise tolerance
and/or performance.
Research investigating GT extracts (GTE) and exercise
have produced conflicting results. Modest EGCG dosage
in the short term (270 mg·d−1 EGCG for 6 days [22],
and 68 mg·d−1 EGCG for 3 weeks [23,24]) did not alter
metabolic or performance variables in healthy or en-
durance trained volunteers. However, the inclusion of
100.5 mg·d−1 EGCG over a 10 week training period en-
hanced whole-body metabolic efficiency elsewhere [11].
One confounding factor though is the use of caffein-
ated GTE in these studies. When decaffeinated GTE
(dGTE) has been employed, 366 mg EGCG was found
to acutely increase fat oxidation by 17% [3]. Conversely,
higher dosage dGTE (624 ± 3 mg·d−1 EGCG for 28 days)
did not significantly affect fat oxidation in healthy, male
volunteers [25].
We were therefore invited to undertake an inde-
pendent assessment of the cardio-metabolic and per-
formance effects of a dGTE formula (571 mg·d−1
GTE providing 400 mg·d−1 EGCG) over a 4 week
period in comparison to placebo in healthy, male
volunteers. It was hypothesised that moderate dose
dGTE would significantly improve fat oxidation and
performance, supporting longer term mechanisms linking




Fourteen healthy, male participants volunteered follow-
ing power calculation assessment (G*Power3, Dusseldorf
[26]; using α = 0.05; 1-β = 0.95; based on observed data
[3,22-24] and 2 groups). Participants were required to be
recreationally active non-smokers, and have no known
sensitivities to tea products or be regular green tea con-
sumers. Prior to study inclusion, all participants provided
written informed consent and satisfactorily completed a
general health screen. The study was approved by the
University of Hertfordshire Life and Medical Sciences
Ethics Committee. Participant characteristics are dis-
played in Table 1.Procedures
Preliminary testing
All testing took place in the Human Physiology Laboratory,
University of Hertfordshire. Participants were instructed
to refrain from consuming caffeinated products for
48 hours prior to initial testing, and not be consuming
other supplementation.
Peak oxygen consumption ( _VO2peak) was assessed at least
one week prior to experimental trials using a standard in-
cremental step protocol increasing by 30 W each 3 minutes
until volitional exhaustion as previously reported [27]. Tests
were performed on a Monark Ergomedic 874E stationary
bike (Monark Exercise AB, Varberg, Sweden) using a
Metalyser 3B automated gas-analyser (Cortex Biophysik,
Leipzig, Germany). On a separate occasion, subjects
undertook a familiarisation trial to confirm exercise
intensity at 50% _VO2peak . This intensity was selected
based on pilot work in which average fat oxidation
rates during sustained submaximal exercise were statisti-
cally greater at 50% _VO2peak compared to both 40 and
60% _VO2peak.
Treatments
Participants were randomly assigned to an experimental
or placebo group, and provided with either capsulated
dGTE (571 mg·d−1 dGTE, delivering 70% or 400 mg·d−1
EGCG (equivalent to 6–7 cups of green tea per day),
Changsha Active Ingredients Group Inc., Changsha,
China*), or placebo (700 mg·d−1 corn flour). All partici-
pants received capsules on a weekly basis to monitor
compliance, with instructions to consume one capsule
daily before breakfast with 250 ml water. *Analysis of
the main active ingredient (EGCG) was undertaken prior to
and independently of the main study by Changsha Active
Ingredients Group Inc., using high performance liquid
chromatography. The certificate of analysis provided by the
supplying company demonstrated that the product con-
tained 91.21% total catechins, from which 70.74% was
EGCG. The product did not appear to be assessed for other
catechins, so it is likely that the remaining percentage com-
prised other catechins (GCG, EGC, GC, EC, ECG, etc.).
Experimental design and intervention
A randomised, double blind, placebo controlled parallel
design was employed over a 4 week intervention. Partici-
pants completed three laboratory trials at week 0, 2 and
4 under controlled conditions following an overnight
fast. Upon arrival, nude body mass (Seca 780, Hamburg,
Germany), height (Seca 200 stadiometer, Hamburg,
Germany) and body composition [28] (Tanita Body
Segmental Analyser 418-BC, Tokyo, Japan) were assessed.
Participants were then fitted with a Polar FS2c telemet-
ric monitor (Polar Electro Ltd., Kempele, Finland) and
Table 1 Baseline characteristics and resting measurements across the intervention
Variable PL (n = 7) dGTE (n = 7)
Age (years) 21.4 ± 0.6 21.4 ± 0.3
Height (m) 1.77 ± 0.03 1.78 ± 0.01
_VO2peak (L·min
−1) 3.13 ± 0.18 2.87 ± 0.08
Baseline Week 2 Week 4 Baseline Week 2 Week 4
Weight (kg) 75.46 ± 2.91 75.11 ± 2.94* 74.81 ± 2.88* 77.29 ± 2.05 76.96 ± 2.03* 76.69 ± 1.95* B
Bodyfat (%) 16.63 ± 1.58 16.34 ± 1.69 15.97 ± 1.69*# 17.06 ± 1.24 16.23 ± 1.39* 15.43 ± 1.33*# A,B
HR (bpm) 61.00 ± 2.70 62.14 ± 1.81 61.00 ± 1.83 62.00 ± 1.25 62.43 ± 2.01 62.57 ± 1.92
SBP (mm Hg) 129.29 ± 1.73 125.71 ± 3.64 127.00 ± 2.44 130.00 ± 1.18 126.57 ± 2.14 126.86 ± 3.64
DBP (mm Hg) 67.57 ± 4.35 66.14 ± 1.72 69.71 ± 2.37 69.57 ± 2.40 65.71 ± 2.55 67.71 ± 2.11
Table 1 shows the key participant characteristics for each group, including absolute changes for weight, body fat, heart rate and blood pressure over the
intervention. Data are presented as mean ± SE. PL, Placebo; dGTE, decaffeinated green tea extract; _VO2peak, peak oxygen uptake; HR, heart rate; SBP, systolic blood
pressure; DBP, diastolic blood pressure. Adenotes significant overall group x time interaction effect (P = 0.002). Bdenotes significant overall time interaction effect
only (P < 0.001). *denotes significant difference (P ≤ 0.05) to baseline only within group. #denotes significant difference to week 2 within group only (P < 0.046).
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pressure readings (Omron MX3 plus, Kyoto, Japan). A
venous wholeblood sample was then collected into dupli-
cate 4 ml K3EDTA Vacutainers (Greiner Bio-One GmbH,
Kremsmunster, Austria) by a qualified phlebotomist.
Samples were centrifuged for 10 minutes at 2000 rpm,
with aliquotted plasma immediately frozen at −80°C for
later assessment of TFA.
Exercise trials
Exercise trials comprised a submaximal assessment and
performance stage. During the submaximal assessment,
participants exercised for one hour at 50% _VO2peak on a
Monark Ergomedic 874E cycle ergometer. Gas exchange
data was recorded continuously throughout exercise
using a Metalyser 3B gas analyser, with average data
taken over the final 45 minutes of submaximal exercise.
Rating of perceived exertion (RPE) [29] and heart rate
were recorded every 20 minutes.
Rates of total carbohydrate oxidation (CHOTOT), total
fat oxidation (FATTOT) (g·min
−1) and energy expenditure
(EE) (kJ·min−1) were calculated from _VO2 and _VCO2
(L·min−1) using stoichiometric equations [30], with pro-
tein oxidation assumed negligible, as follows:
CHOTOT ¼ 4:210 • ð VCO2Þ– 2:962 • ð VO2Þ ð1Þ
FATTOT ¼ 1:695 • ð VO2Þ– 1:701 • ð VCO2Þ ð2Þ
EE ¼ ½ð0:550 • VCO2Þ– ð4:471 • VO2Þ • 4:2 ð3Þ
Upon completion, seated blood pressure and post
exercise venous sampling was repeated as previously
described. Following this, participants were instructed
to undertake a 40 minute self-paced performance trial
using a Computrainer erogometer system (RaceMateInc., Seattle, USA). Distance covered (km) and power
output (W) were recorded each 10 minutes, with only
time elapsed visible to the subjects. Verbal encouragement
was provided each 10 minutes. At the end of the exercise
trial, subjects recovered for 5 minutes at 50 W.Dietary intake and exercise activity
All participants recorded a 3 day dietary recall preceding
each exercise trial to assess for habitual dietary compliance.
Dietary analyses were undertaken using Dietplan 6.50
(Forestfield Software Ltd, West Sussex, United Kingdom),
with no differences reported between groups for macro-
nutrients and/or energy intake. Additionally, partici-
pants were requested to consume similar meals the day
before the exercise trials at regular time intervals to
provide increased control of oxidation variables. This was
based on pilot work assessment of fat oxidation stability at
50% _VO2peak (assessed by calculating the amount of time
(minutes) throughout the exercise that was spent
within ±0.02 g·min−1 of the average fat oxidation rate,
expressed as a percentage for each individual), which
was greater when the 24 hour pre exercise period was
controlled for dietary intake (68.22 ± 5.70%) compared
to when only the evening meal preceding the testing
session was controlled (60.78 ± 8.42%).
The standardised menu was based on typical foods
consumed by participants at breakfast, lunch and
dinner, and provided similar caloric intake to habitual
dietary records (values as calorie totals and per kilogram
mean bodyweight: energy intake: 2484.70 kcal·d−1
(32.68 kcal·kg−1·d−1); carbohydrate: 1127.7 kcal·d−1
(14.83 kcal·kg−1·d−1); fat: 565.4 kcal·d−1 (7.43 kcal·kg−1·d−1)
and protein: 791.96 kcal·d−1 (10.42 kcal·kg−1·d−1).
Throughout the intervention period, participants were
instructed to minimise consumption of polyphenol
rich foods. Participants were additionally required to
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as part of a regulated exercise programme. All partici-
pants provided training diaries to monitor compliance.Blood analyses
All blood analyses for TFA were independently under-
taken by ABS Laboratories (Biopark, Welwyn Garden
City, Hertfordshire) employing previously validated
methods [31]. TFA concentrations were based on assess-
ment of palmitic, palmitoleic, stearic, oleic and linoleic
acids. Briefly, 100 μl plasma aliquots were spiked with
internal standard (heptadecanoic acid), with free fatty
acids being extracted using the ‘Dole Extraction Solvent’
(isopropanol/heptane/sulphuric acid (1 M) (40:10:1)).
After drying under nitrogen, the extracts were re-
suspended using 200 μL of dichoromethane and the
FFAs derivatised using diethylamine and Deoxo-Fluor.
The diethylamide derivatives were then extracted into
heptane. The heptane was then removed using nitrogen
in a dry-block at 70°C. The dried extracts were reconsti-
tuted into 100 μL of heptane and quantified by gas chro-
matography using a mass spectrometer as the detector in
the selected ion monitoring (SIM) mode.100
(%
) 90
EE (kJ) 1941.24     
±93.34
             189
± 9
0.09          
6.34




Statistical analyses were performed using SPSS (v19,
Chicago, USA). Baseline variables were assessed using
an independent samples t-test. A mixed design repeated
measures analysis of variance (ANOVA) was employed
to assess treatment and time interactions. Where pertinent,
a one way ANOVA with Bonferroni post hoc adjustments
was utilised to assess within treatment effects. An alpha
level of ≤0.05 was employed for statistical significance. Data































Figure 1 Weekly contribution of substrate to total energy
expenditure (EE) for the PL group. Figure 1 shows the contribution
of both fat and carbohydrate (based on oxidation rates) to energy
expenditure during submaximal exercise for the placebo condition.
Data are presented as mean ± SE. PL, Placebo; FAT, average fat
oxidation rates; CHO, average carbohydrate oxidation rates. No
significant differences were found with ANOVA (P > 0.05).Results
Baseline characteristics and resting measures
Intervention groups were matched for age, height,
weight, body fat and _VO2peak at baseline (Table 1). A
significant interaction effect for bodyweight was found
across time only (F = 16.98, P < 0.001). Net bodyweight
reduction was similar between groups across the inter-
vention (0.64 ± 0.17 kg for PL; F = 12.33, P = 0.001;
ηp2 = 0.67), and 0.60 ± 0.21 kg for dGTE; F = 6.27,
P = 0.014; ηp2 = 0.51 within group). There was a sig-
nificant group x time interaction for percentage body
fat (F = 7.81, P = 0.002), with an overall reduction of
1.63 ± 0.16% with dGTE (P < 0.001; ηp2 = 0.84 within
group) compared to 0.66 ± 0.15% for PL (P = 0.002; ηp2 =
0.66 within group). No significant effects were reported
for resting heart rate or blood pressure.Submaximal exercise measures
Weekly contribution of substrate to total energy expend-
iture (EE) for PL and dGTE are reported in Figures 1
and 2 respectively. No significant differences were re-
ported for EE either between or within groups over time
(P > 0.05), demonstrating consistency of the submaximal
exercise trials.
A significant overall group x time interaction for
FATTOT was observed (F = 3.39, P = 0.05). FATTOT during
exercise remained similar for PL across the intervention
period (week 0 = 0.277 ± 0.038 g·min−1; week 2 = 0.274 ±
0.031 g·min−1; week 4 = 0.279 ± 0.030 g·min−1, P > 0.05)
despite a non-significant increase in percentage contribu-
tion to total EE (week 0 = 34.61 ± 3.72%; week 2 = 35.23 ±
2.99%; week 4 = 35.53 ± 2.53%, P > 0.05).
FATTOT for dGTE increased from 0.241 ± 0.025 g·min
−1
at week 0 to 0.256 ± 0.023 g·min−1 at week 2, and to
0.301 ± 0.009 g·min−1 by week 4 (F = 4.10, P =0.05;
ηp2 = 0.45). This represented a 24.9% or 0.060 ±
0.027 g·min−1 increase in FATTOT with dGTE. Corres-
pondingly, percentage contribution of total fat to exercise
EE increased with dGTE from 32.61 ± 3.53% at week 0 to
34.71 ± 2.57% at week 2, and to 41.45 ± 1.31% at week 4
(F = 4.28, P = 0.045; ηp2 = 0.46).
A significant time interaction was observed only
for CHOTOT (F = 4.28, P = 0.028). CHOTOT reduced
with dGTE from 1.203 ± 0.078 g·min−1 at week 0, to
1.144 ± 0.044 g·min−1 at week 2, and finally to 1.025 ±
0.048 g·min−1 by week 4, representing a reduction of 14.8%
or 0.178 ± 0.069 g·min−1 (F = 4.02, P = 0.05; ηp2 = 0.45).
Figure 2 Weekly contribution of substrate to total energy
expenditure (EE) for the dGTE group. Figure 2 shows the
contribution of both fat and carbohydrate (based on oxidation rates)
to energy expenditure during submaximal exercise for the dGTE
condition. Data are presented as mean ± SE. dGTE, decaffeinated green
tea extract; FAT, average fat oxidation rates; CHO, average carbohydrate
oxidation rates. Adenotes significant overall group × time interaction
effect compared with PL (Figure 1; P= 0.05). Bdenotes significant overall
time interaction effect in conjunction with PL (Figure 1; P≤ 0.03).
1 denotes significant interaction over time within GTE only (P≤ 0.05).
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to exercise EE also reduced with dGTE from 67.39 ±
3.53% at week 0 to 65.28 ± 2.57% at week 2, and to
58.55 ± 1.31% at week 4 (F = 4.28, P = 0.045; ηp2 = 0.46).
CHOTOT and contribution of CHO to EE were largely
unaffected with PL (P > 0.05).
Despite an improvement in FATTOT for dGTE, no sig-
nificant differences were observed for TFA concentrations
either within or between groups pre-post intervention
(Figure 3, P > 0.05). It was however noted that TFA con-
centrations were elevated pre-exercise by week 4 with PL
(249.3 ± 46.2 μM·L−1 at week 0 to 315.4 ± 98.1 μM·L−1 at
week 4, a 26.5% increase, P > 0.05) and dGTE (227.9 ±
37.6 μM·L−1 at week 0 to 289.7 ± 54.8 μM·L−1 at week 4, a
27.1% increase, P > 0.05), with lack of significance most
likely explained by individual variance.
It was also noted that whereas TFA concentrations
reduced by 18.8% post exercise in the PL group from
616.5 ± 114.8 μM·L−1 at week 0 to 500.3 ± 141.8 μM·L−1
at week 4; post exercise TFA concentrations were main-
tained with dGTE (509.3 ± 90.0 μM·L−1 at week 0 to
514.3 ± 71.1 μM·L−1 at week 4), although no significant
differences were reported within or between groups
(P > 0.05). No significant differences were reported for
any of the individual fatty acids measured.
Submaximal oxygen uptake values were not different
across time either within or between groups (Table 2)demonstrating compliance to the set intensity (P > 0.05).
No significant interaction effects were found for expired
carbon dioxide, despite a modest reduction in _VCO2
during submaximal exercise with dGTE from 1.31 ±
0.05 L·min−1 at week 0, to 1.25 ± 0.05 L·min−1 at week
4 (P > 0.05). However, in conjunction with improved
FATTOT, a significant overall group × time interaction
was observed for the respiratory exchange ratio (RER;
F = 3.30, P = 0.05), with values reducing from 0.90 ± 0.01
at week 0 to 0.87 ± 0.01 at week 4 (F = 4.36, P = 0.044;
ηp2 = 0.47, within group) supporting reduced reliance
on CHO with dGTE. No such modifications for RER
were observed with PL (P > 0.05).
Although submaximal exercise heart rate reduced by
6.24 ± 3.85 b·min−1 (4.8% by week 4) in the PL group,
significance across time was only found with dGTE
where submaximal exercise heart rate reduced by 8.8%
from 124.95 ± 3.69 b·min−1 at week 0 to 113.90 ± 4.03
b·min−1 at week 4 (F = 4.07, P = 0.045; ηp2 = 0.40). A
significant overall group × time interaction was also
found for RPE (F = 3.43, P = 0.05), with subjects perceiving
exercise to be progressively easier with dGTE by week 4
(10.0 ± 0.6 relative effort rating) compared to week 0
(11.9 ± 0.4; P = 0.015; ηp2 = 0.58). No differences were
reported for systolic or diastolic blood pressure immedi-
ately post exercise over time for either group (P > 0.05).Performance measures
A significant overall group × time interaction was found
for distance covered (F = 9.84, P = 0.001; Figure 4). The
use of dGTE resulted in a progressive increase in
distance covered from 20.23 ± 0.54 km at week 0, to
21.77 ± 0.49 km at week 2 and finally 22.43 ± 0.40 km by
week 4, representing a 10.9% significant increase in per-
formance (F = 28.66, P < 0.001; ηp2 = 0.85). A similar inter-
action effect was also observed for PL (F = 7.94, P = 0.009;
ηp2 = 0.61) with distance covered significantly improv-
ing by week 2 (21.75 ± 0.40 km) compared to week 0
(20.79 ± 0.30 km; P = 0.002) only.
In a similar manner, a significant overall group × time
interaction was found for average power output (F = 14.43,
P < 0.001; Figure 4). Average power output increased with
dGTE (F = 40.01, P < 0.001; ηp2 = 0.89) by 17.9% or 29.02 ±
5.53 W from week 0 (162.06 ± 10.08 W) to week 2
(191.08 ± 10.85 W; P = 0.01); and by 22.7% (or 36.85 ±
3.20 W) from week 0 to week 4 (198.91 ± 8.61 W;
P <0.001), but was not significantly different between week
2 and 4 (P > 0.05). No significant differences across time
for average power output were observed for PL (P > 0.05).Discussion
The use of a 4 week dGTE strategy significantly enhanced
FATTOT by 24.9% or 0.060 ± 0.027 g·min
−1 compared to
Figure 3 Total fatty acid concentrations pre and post exercise. Figure 3 shows the absolute total fatty acid concentrations at rest and post
exercise for both treatment conditions at week 0 and week 4. Data are presented as mean ± SE. PL, Placebo; dGTE, decaffeinated green tea
extract. No significant differences were found with ANOVA (P > 0.05).
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tion of total fat to EE with dGTE supports the proposal
that EGCG positively influences substrate utilisation, par-
ticularly in combination with exercise training. The use of
a capsulated dGTE formula in the present study poten-
tially offers a more practical means to regularly consume a
sufficient daily dosage to elicit such effects (compared to
consumption of ~6-7 cups of green tea per day, especially
considering the notable variability of catechin content in
commercial green teas).
Improvements in FATTOT have been demonstrated
elsewhere [1,11,32], with current values comparable to
those reported when employing an acute dGTE strategy
with similar EGCG content [3]. Conversely, higher doseTable 2 Assessment of oxygen uptake, mean heart rate, perce
exercise
PL (n = 7)
Variable Week 0 Week 2 Week 4
_VO2 (L·min
−1) 1.55 ± 0.08 1.51 ± 0.08 1.52 ± 0
_VCO2 (L·min
−1) 1.38 ± 0.06 1.35 ± 0.06 1.35 ± 0
RER 0.89 ± 0.01 0.89 ± 0.01 0.89 ± 0
HR (b·min−1) 127.8 ± 5.5 122.7 ± 4.4 121.5 ±
RPE (6–20) 11.1 ± 0.8 11.7 ± 0.6 11.6 ± 0
SBP (mm Hg) 132.7 ± 2.9 127.4 ± 3.0 127.7 ±
DBP (mm Hg) 80.1 ± 3.3 74.7 ± 1.9 73.0 ± 2
Table 2 demonstrates the influence of the dGTE on cardio-respiratory measures dur
presented as mean ± SE. PL, Placebo; dGTE, decaffeinated green tea extract; _VO2, su
respiratory exchange ratio; HR, heart rate; RPE, rating of perceived exertion; SBP, sys
group x time interaction effect (P ≤ 0.05). Bdenotes significant overall time interactio
effect only (P ≤ 0.045). *denotes significant difference within group to baseline (P =dGTE over a 28 day period did not enhance substrate
metabolism in healthy, male volunteers [25] in contrast
to these findings. However, in this latter study, the
higher FATTOT are more typical of endurance trained
athletes. It has been inferred that the combined effect of
exercise training and GTE may be more relevant for un-
trained individuals who ‘respond’ to GTE intervention
[25]. Participants in this study were recreationally active.
It is therefore plausible that adaptations in exercise metab-
olism with dGTE are more pronounced with less trained
individuals, as opposed to physically active or endurance
trained volunteers assessed elsewhere [23-25].
Improved FATTOT, and reduced reliance on CHOTOT
during exercise are of clinical and performance relevance.ived exertion and blood pressure related to submaximal
dGTE (n = 7)
Week 0 Week 2 Week 4
.06 1.46 ± 0.04 1.44 ± 0.04 1.44 ± 0.05
.05 1.31 ± 0.05 1.29 ± 0.03 1.25 ± 0.05
.01 0.90 ± 0.01 0.89 ± 0.01 0.87 ± 0.01 1 A,B
3.8 124.9 ± 3.7 117.0 ± 2.5 113.9 ± 4.0 1 B
.3 11.9 ± 0.4 11.2 ± 0.4 10.0 ± 0.6* A
2.9 132.3 ± 2.4 127.6 ± 1.8 126.3 ± 2.9
.0 74.4 ± 1.8 76.6 ± 5.1 70.1 ± 3.5
ing submaximal steady state exercise across the intervention. Data are
bmaximal oxygen uptake; _VCO2, submaximal expired carbon dioxide; RER,
tolic blood pressure; DBP, diastolic blood pressure. Adenotes significant overall
n effect only (P ≤ 0.02). 1denotes significant within group time interaction
0.015).
Figure 4 Distance covered and average power output during the performance trial. Figure 4 shows the distance covered and average
power output elicited during the 40 minute performance trial for both treatment conditions at week 0, 2 and 4 of the intervention. Data are
presented as mean ± SE. PL, Placebo; dGTE, decaffeinated green tea extract. Adenotes significant overall group × time interaction effect (P≤ 0.001).
Bdenotes significant overall time interaction effect (P < 0.001). 1denotes significant within group time interaction effect only (P = 0.039). *denotes
significant difference (P≤ 0.02) to baseline only within group. #denotes significant difference to week 2 within group only (P = 0.03).
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cantly different between groups, the increase in FATTOT
with dGTE supports the contention that the inhibition of
COMT may not be a dominant mechanism.
Independently of antioxidant protective mechanisms,
it has been proposed that EGCG positively modulates
cell signalling via PGC1α [20], sirtuin 1 (SIRT1) and
mitogen activated protein kinase (MAPK) pathways
[33,34]. In the longer term (>4 weeks), it is feasible that
EGCG at moderate dose facilitates up-regulation of gene
expression leading to enhanced FATTOT with exercise.
Although bodyweight reductions were similar between
groups, the use of dGTE combined with regulated exercise
significantly reduced body fat compared to PL. These find-
ings are similar to those reported elsewhere [10,32,35],
particularly when either higher dose GTE or low dose caf-
feine has been employed. Alterations in body composition,
coupled with increased FATTOT infer that catechin poly-
phenols favourably modulate cellular metabolism, possibly
via a calorie restriction mimetic (CRM) action [36]. This
contention is further supported via studies demonstrating
enhanced glucose tolerance, insulin sensitivity and adipo-
nectin levels with EGCG [3,37].
In the current study, resting and submaximal exercise
heart rate and blood pressure decreased over the inter-
vention period in both groups. However, results were
only significant over time with dGTE for exercising heart
rate and perceived exertion, possibly relating to substrate
utilisation efficiency and improved exercise economy.
Additionally, whilst the results could also indicate anacute training stimulus, non-significant reductions in
SBP found were comparable to those observed elsewhere
[10,13,37]. It is therefore suggested that any mild
hypotensive effects are likely due to the short-term in-
fluence of regular aerobic activity on nitric oxide path-
ways than dGTE impacting on endothelial production
of nitric oxide synthase.
There has been much interest in the use of GTE to
enhance physical performance. In animal studies, time
to exhaustion has been shown to improve with GTE by
8-24%, with corresponding evidence of increased ß-oxida-
tion and fatty acid translocase/CD36 mRNA expression
[38]. When relatively low GTE/EGCG doses have been
employed in humans, improvements in time trial or per-
formance measures have not been observed [22,24].
However, the inclusion of matched caffeine placebo or
pre-exercise feeding may explain these findings. Con-
versely, with higher dose GTE strategies, improvements
in maximal oxygen uptake and time trial performance
have been observed [39,40].
To the authors’ knowledge, this is the first study to
demonstrate a significant impact of dGTE on subse-
quent exercise performance. Performance indices im-
proved by 10.9% for distance covered, and 22.7% for
average power output with dGTE. This is unlikely to
be fully explained via a training effect as improve-
ments with PL were only observed at week 2 of the
trial. Reduced reliance on CHOTOT may have contrib-
uted to improved performance following submaximal
exercise.
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from dGTE on exercise tolerance, performance and re-
covery is warranted, particularly in light of metabolomic
advances [41]. High dose GTE has been demonstrated to
reduce muscle soreness following strenuous exercise
[42], potentially via signalling interactions leading to
reduced post exercise inflammatory cascades [43]. Results
in the current study may have been augmented due to
utilisation of a low polyphenol diet. Further research
combining dietary polyphenols with dGTE is warranted.Conclusions
In conclusion, dGTE in conjunction with exercise train-
ing reduced relative FATTOT and body composition in
recreationally active, male volunteers. Improved metabolic
efficiency during submaximal exercise may potentiate im-
proved metabolic economy and hence adherence to longer
term training programmes. Combined with the observed
impact of dGTE on subsequent performance indices, this
supports the contention that EGCG use may modulate
cellular signalling pathways leading to more efficient
substrate use, resulting in improved exercise output.
Abbreviations
CHO: Carbohydrate; CHOTOT: Total carbohydrate oxidation rate (measured
in g·min−1); COMT: Catechol-o-methyl transferase; dGTE: Decaffeinated
green tea extract; EE: Energy expenditure (measured in kJ·min−1);
EGCG: (−)-Epigallocatechin-3-gallate; FATTOT: Total fat oxidation rate
(measured in g·min−1); GT: Green tea; PL: Placebo formula used in the
study; RER: Respiratory exchange ratio the ratio from dividing expired
carbon dioxide with oxygen uptake; RPE: Rating of perceived exertion;
TFA: Total fatty acids; _VO2: Volume of oxygen uptake (measured in L·min
−1);
_VO2peak: Peak oxygen uptake (measured in L·min
−1); _VCO2: Volume of expired
carbon dioxide (measured in L·min−1).
Competing interests
Research funding and product supply to support this study was received
from High 5 Ltd. All data was collected, analysed and reported by the
investigatory team fully independently of the company. The authors declare
that they have no competing interest.
Authors’ contributions
All authors were involved in the study. JDR was the principal researcher,
involved with liaison with the company, project organisation, statistical
analysis and manuscript generation; MGR was co-supervisor involved with
project co-ordination, quality control and technical accuracy in preparation
of the manuscript; MDT was involved with confirmation of statistical analyses,
and manuscript editing; JCW and CHT were involved with participant recruitment,
pilot data collection, experimental interventions, data analysis and manuscript
editing. All authors read and approved the final manuscript.
Acknowledgements
The authors wish to acknowledge High5 Ltd. for providing the support
and funding to undertake this study. dGTE was supplied by High 5 Ltd.
independently of the investigatory team. The authors also wish to
acknowledge the support and external collaboration with ABS
Laboratories, Biopark, Welwyn Garden City, for independent
assessment of blood samples.
Received: 6 November 2014 Accepted: 16 December 2014References
1. Dulloo AG, Duret C, Rohrer D, Girardier L, Mensi N, Fathi M, et al. Efficacy of
a green tea extract rich in catechin polyphenols and caffeine in increasing
24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr.
1999;70:1040–50.
2. Ryu OH, Lee J, Lee KW, Kim HY, Seo JA, Kim SG, et al. Effects of green tea
consumption on inflammation, insulin resistance and pulse wave velocity in
type 2 diabetes patients. Diabetes Res Clin Pract. 2006;71:356–8.
3. Venables MC, Hulston CJ, Cox HR, Jeukendrup AE. Green tea extract ingestion,
fat oxidation, and glucose tolerance in healthy humans. Am J Clin Nutr.
2008;87:778–84.
4. Mukhtar H, Ahmad N. Tea polyphenols: prevention of cancer and
optimizing health. Am J Clin Nutr. 2000;71(6):1698S–702.
5. Maki KC, Reeves MS, Farmer M, Yasunaga K, Matsuo N, Katsuragi Y, et al.
Green tea catechin consumption enhances exercise-induced abdominal fat
loss in overweight and obese adults. J Nutr. 2009;139(2):264–70.
6. Moore RJ, Jackson KG, Minihane AM. Green tea (Camellia Sinensis) catechins
and vascular function. Br J Nutr. 2009;102(12):1790–802.
7. Nantz MP, Rowe CA, Bukowski JF, Percival SS. Standardised capsule of
Camellia sinensis lowers cardiovascular risk factors in a randomized,
double-blind, placebo-controlled study. Nutr. 2009;25(2):147–54.
8. Valcic S, Burr JA, Timmermann BN, Liebler TC. Antioxidant chemistry of
green tea catechins. New oxidation products of (−)-epigallocatechin gallate
and (−)-epigallocatechin from their reactions with peroxyl radicals. Chem
Res Toxicol. 2000;13(9):801–10.
9. Henning SM, Niu Y, Lee NH, Thames GD, Minutti RR, Wang H, et al.
Bioavailability and antioxidant activity of tea flavanols after consumption of
green tea, black tea, or a green tea extract supplement. Am J Clin Nutr.
2004;80:1558–64.
10. Nagao T, Hase T, Tokimitsu I. A green tea extract high in catechins reduces
body fat and cardiovascular risks in humans. Obesity. 2007;15(6):1473–83.
11. Ichinose T, Nomura S, Someya Y, Akimoto S, Tachiyashiki K, Imaizumi K.
Endurance training supplemented with green tea extract on substrate
metabolism during exercise in humans. Scand J Med Sci Sports.
2011;21:598–605.
12. Galleano M, Pechanova O, Fraga CG. Hypertension, nitric oxide, and dietary
plant polyphenols. Curr Pharm Biotech. 2010;11(8):837–48.
13. Brown AL, Lane J, Coverly J, Stocks J, Jackson S, Stephen A, et al. Effects of
dietary supplementation with the green tea polyphenol epigallocatechin-3-
gallate on insulin resistance and associated metabolic risk factors: a
randomised control trial. Br J Nutr. 2009;101(6):886–94.
14. Rains TM, Agarwal S, Maki KC. Antiobesity effects of green tea catechins: a
mechanistic review. J Nutr Biochem. 2011;22(1):1–7.
15. Phung OJ, Baker WL, Matthews LJ, Lanosa M, Thorne A, Coleman CI. Effect
of green tea catechins with or without caffeine on anthropometric
measures: a systematic review and meta-analysis. Am J Clin Nutr.
2010;91(1):73–81.
16. Hursel R, Viechtbauer W, Westerterp-Plantenga MS. The effects of green tea
on weight loss and weight maintenance: A meta-analysis. Int J Obes.
2009;33(9):956–61.
17. Hursel R, Westerterp-Plantenga MS. Thermogenic ingredients and body
weight regulation. Int J Obes. 2010;34(4):659–69.
18. Feng WY. Metabolism of green tea catechins: An overview. Curr Drug
Metab. 2006;7(7):755–809.
19. Chen C, Wang CY, Lambert JD, Ali N, Welsh WJ, Yang CS. Inhibition of
human liver catechol-O-methyltransferase by tea catechins and their
metabolites: structure-activity relationship and molecular-modelling studies.
Biochem Pharma. 2005;69(10):1523–31.
20. Hodgson AB, Randell RK, Jeukendrup AE. The effect of green tea extract on
fat oxidation at rest and during exercise: Evidence of efficacy and proposed
mechanisms. Adv Nutr. 2013;4:129–40.
21. Reiter CEN, Kim JA, Kwon MJ. Green tea polyphenol epigallocatechin gallate
reduces endothelin-1 expression and secretion in vascular endothelial cells:
Roles for AMP activated protein kinase, Akt and FOXO1. Endocrinol.
2009;151(1):103–14.
22. Dean S, Braakhuis A, Paton C. The effects of EGCG on fat oxidation and
endurance performance in male cyclists. Int J Sport Nutr Exerc Metab.
2009;20(6):624–44.
23. Eichenberger P, Colombani PC, Mettler S. Effects of a 3-week consumption
of green tea extracts on whole-body metabolism during cycling exercise in
endurance-trained men. Int J Vitam Nutr Res. 2009;79(1):24–33.
Roberts et al. Journal of the International Society of Sports Nutrition  (2015) 12:1 Page 9 of 924. Eichenberger P, Mettler S, Arnold M, Colombani PC. No effects of three-week
consumption of a green tea extract on time trial performance in endurance
trained men. Int J Vitam Nutr Res. 2010;80(1):54–64.
25. Randell RK, Hodgson AB, Lotito SB, Jacobs DM, Rowson M, Mela DJ. Variable
duration of decaffeinated green tea extract ingestion on exercise
metabolism. Med Sci Sports Exerc. 2014;46(6):1185–93.
26. Faul F, Erdfelder E, Lang A-G, Buchner A. G*power 3: a flexible statistical
power analysis program for the social, behavioral, and biomedical sciences.
Behav Res Meth. 2007;39(2):175–91.
27. Roberts JD, Tarpey MD, Kass LS, Tarpey RJ, Roberts MG. Assessing a
commercially available sports drink on exogenous carbohydrate oxidation,
fluid delivery and sustained exercise performance. J Int Soc Sports Nutr.
2014;11(8):1–14.
28. Kao M-F, Lu H-K, Jang T-R, Yang W-C, Chen C-H, Chen Y-Y, et al. Comparison
of different measurement equations for body composition estimation in
male athletes. Int J Sport Exerc Sci. 2010;3(1):11–6.
29. Borg G. Ratings of perceived exertion and heart rates during short term
cycle exercise and their use in a new strength test. Int J Sports Med.
1982;3(3):153–8.
30. Jeukendrup AE, Wallis GA. Measurement of substrate oxidation during
exercise by means of gas exchange measurements. Int J Sports Med.
2005;26(1):S28–37.
31. Kangani CO, Kelley DE, DeLany JP. New method for GC/FID and GC-C-IRMS
analysis of plasma free fatty acid concentration and isotopic enrichment.
J Chromatogr B Analyt Technol Biomed Life Sci. 2008;873(1):95–101.
32. Westerterp-Plantenga MS, Lejeune MPGM, Kovacs EMR. Body weight loss
and weight maintenance in relation to habitual caffeine intake and green
tea supplementation. Obes Res. 2005;13:1195–204.
33. Ayissi VBO, Ebrahimi A, Schluesenner H. Epigenetic effects of natural
polyphenols: a focus on SIRT1-mediated mechanisms. Mol Nutr Food Res.
2014;58:22–32.
34. Kim H-S, Quon MJ, Kim J-A. New insights into the mechanisms of polyphenols
beyond antioxidant properties: lessons from the green tea polyphenol,
epigallocatechin 3-gallate. Redox Biol. 2014;2:187–95.
35. Wang H, Wen Y, Du Y, Yan X, Guo H, Rycroft JA, et al. Effects of catechin
enriched green tea on body composition. Obesity. 2010;18:773–9.
36. Madeo F, Pietrocola F, Eisenberg T, Kroemer G. Calorie restriction mimetics:
towards a molecular definition. Nat Rev: Drug Disc. 2014;13(10):727–40.
37. Potenza MA, Marasciulo FL, Tarquinio M, Tiravanti E, Colantuono G, Federici
A, et al. EGCG, a green tea polyphenol, improves endothelial function and
insulin sensitivity, reduces blood pressure, and protects against myocardial
I/R injury in SHR. Am J Physiol Endocrinol Metab. 2007;292:E1378–87.
38. Murase T, Haramizu S, Shimotoyodome A, Tokimitsu I, Hase T. Green tea
improves running endurance in mice by stimulating lipid utilization during
exercise. Am J Physiol Reg Integr Comp Physiol. 2006;290(6):R1550–6.
39. MacRae HSH, Mefferd KM. Dietary antioxidant supplementation combined
with quercetin improves cycling time trial performance. Int J Sport Nutr
Exer Metab. 2006;16(4):405–19.
40. Richards JC, Lonac MC, Johnson TK, Schweder MM, Bell C. Epigallocatechin-
3-gallate increases maximal oxygen consumption in adult humans. Med Sci
Sports Exerc. 2010;42(4):739–44.
41. Nieman DC, Gillitt ND, Knab AM, Shanely RA, Pappan KL, Jin F, et al.
Influence of a polyphenol-enriched protein powder on exercise-induced
inflammation and oxidative stress in athletes: a randomized trial using a
metabolomics approach. Plos One. 2013;8(8):1–11.
42. Moradpourian MR, Ashkavand Z, Venkatesh C, Vishwanath BS. Effect of
different doses of green tea on oxidative stress and muscle soreness in
downhill treadmill running. Asian J Pharm Clin Res. 2014;7(2):192–3.
43. Cunha CA, Lira FS, Neto JCR, Pimentel GD, Souza GIH, da Silva CMG, et al.
Green tea extract supplementation induces the lipolytic pathway,
attenuates obesity, and reduces low-grade inflammation in mice fed a
high-fat diet. Mediators Inflamm. 2013;2013:1–8.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
